Zymeworks authorizes $125M share repurchase program, expects cash runway beyond 2028

Zymeworks Inc.

Board authorized up to $125M share repurchase of common stock under 2026 program.
Prior 2025 program terminated; 4,197,553 shares repurchased at avg $24.36 for $102.3M.
Company expects existing cash plus $440M milestone payments for Ziihera to fund operations beyond 2028.
Approximately 73.0M shares outstanding as of May 13, 2026.

item 8.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.